Displaying 1 - 50 of 186299 results
Released Company Title Industry Topic
31 Jan 2024
22:26 CET
PERSHING SQUARE HOLDING Pershing Square Holdings, Ltd. Announces Transactions in Own Shares and Weekly Summary of Transactions in Own Shares – 31 January 2024 30204000 Closed End Investments Other subject
31 Jan 2024
22:15 CET
NANOBIOTIX Nanobiotix to Present at the Guggenheim 6th Annual Biotechnology Conference 20103010 Biotechnology Meetings / events
31 Jan 2024
22:15 CET
NANOBIOTIX Nanobiotix participera à la 6ème conférence annuelle de Biotechnologie de Guggenheim 20103010 Biotechnology Meetings / events
31 Jan 2024
22:01 CET
GALAPAGOS Galapagos completes transaction to transfer Jyseleca® business to Alfasigma 20103010 Biotechnology Other subject
31 Jan 2024
22:01 CET
GALAPAGOS Galapagos rondt transactie af om Jyseleca® business over te dragen aan Alfasigma 20103010 Biotechnology Other subject
31 Jan 2024
21:59 CET
MEDINCELL S.A. Le partenaire de MedinCell, Teva, donne des prévisions de vente 2024 pour UZEDY™ et fait le point sur le candidat-traitement d’olanzapine injectable à action prolongée 20103010 Biotechnology New
31 Jan 2024
21:59 CET
MEDINCELL S.A. MedinCell’s Partner Teva Provides Guidance for UZEDY in 2024 and an Update on the Treatment-Candidate of Olanzapine Long-Acting Injectable (LAI) 20103010 Biotechnology New
31 Jan 2024
21:44 CET
ALTERNUS ENERGY GROUP PLC Affiliate Investor Presentation 65101010 Alternative Electricity Non-regulatory press releases
31 Jan 2024
21:30 CET
NORDEA BANK Nordea Bank Abp: Repurchase of own shares on 31.01.2024 30101010 Banks Acquisition or disposal of the issuer’s own shares
31 Jan 2024
20:40 CET
NORDIC MINING Nordic Mining ASA: Interim CFO 55102000 General Mining Additional regulated information required to be disclosed under the laws of a Member State
31 Jan 2024
19:50 CET
SAFE SAFE - Lettre aux actionnaires 20102015 Medical Supplies -
31 Jan 2024
19:07 CET
Protector Forsikring ASA 2023: CR 88.5 %, earnings per share NOK 18.3 30302010 Full Line Insurance Half yearly financial reports and audit reports/limited reviews
31 Jan 2024
19:07 CET
Protector Forsikring ASA Key information relating to the declared cash dividend to be paid by Protector Forsikring ASA 30302010 Full Line Insurance Additional regulated information required to be disclosed under the laws of a Member State
31 Jan 2024
19:03 CET
SYNERGIE SYNERGIE : Grace à sa stratégie de diversification et d’internationalisation, SYNERGIE continue de croitre malgré un marché en repli, et franchit le cap des 3,1 Md€ 50205025 Business Training and Employment Agencies Commercial results
31 Jan 2024
19:03 CET
SYNERGIE SYNERGIE: Despite tough market conditions, SYNERGIE continues to grow and reaches the €3.1 billion milestone. 50205025 Business Training and Employment Agencies Commercial results
31 Jan 2024
19:00 CET
BOUSSARD GAVAUDAN HOLD LTD GBP BOUSSARD & GAVAUDAN HOLDING LIMITED (GBP) : Transaction in Own Shares 30204000 Closed End Investments Other financial transaction
31 Jan 2024
19:00 CET
PHARNEXT Levée de fonds de 250 mille euros 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
31 Jan 2024
19:00 CET
Boussard Gavaudan BOUSSARD & GAVAUDAN HOLDING LIMITED (EUR) : Transaction in Own Shares 30204000 Closed End Investments Other financial transaction
31 Jan 2024
18:45 CET
FNAC DARTY Information relative au contrat de liquidité 40401030 Specialty Retailers Other subject
31 Jan 2024
18:45 CET
FNAC DARTY Information about the liquidity contract 40401030 Specialty Retailers Other subject
31 Jan 2024
18:40 CET
BNP PARIBAS BNP Paribas SA : Recomposition du résultat distribuable 9M23 30101010 Banks Other subject
31 Jan 2024
18:40 CET
BNP PARIBAS BNP PARIBAS SA: Restatement of 9M23 Distributable Net Income 30101010 Banks Other subject
31 Jan 2024
18:38 CET
KAUFMAN ET BROAD Kaufman & Broad SA: ANNUAL RESULTS 2023 40202010 Home Construction Income
31 Jan 2024
18:38 CET
KAUFMAN ET BROAD Kaufman & Broad SA: RESULTATS ANNUELS 2023 40202010 Home Construction Income
31 Jan 2024
18:34 CET
VALERIO THERAPEUTICS Half-Year Liquidity Contract Statement for Valerio Therapeutics 20103010 Biotechnology Other financial transaction
31 Jan 2024
18:34 CET
VALERIO THERAPEUTICS Bilan semestriel du contrat de liquidité de la société Valerio Therapeutics 20103010 Biotechnology Other financial transaction
31 Jan 2024
18:30 CET
POULAILLON ALPOU - Groupe POULAILLON chiffre d\'affaires du T1 2023-2024 et focus sur les activités 45102020 Food Products Corporate life
31 Jan 2024
18:30 CET
International Petroleum Corpor International Petroleum Corporation Announces Results of Normal Course Issuer Bid and Updated Share Capital - Acquisition or disposal of the issuer’s own shares
31 Jan 2024
18:30 CET
PIONEER PROPERTY GROUP Key information relating to the Q1 2024 PPG PREF dividend 35101010 Real Estate Holding and Development Additional regulated information required to be disclosed under the laws of a Member State
31 Jan 2024
18:26 CET
GROUPE CRIT GROUPE CRIT: Déclaration des transactions sur actions propres réalisées le 25 janvier 2024 50205025 Business Training and Employment Agencies Other subject
31 Jan 2024
18:17 CET
SHELL PLC Voting Rights and Capital 60101000 Integrated Oil and Gas Other subject
31 Jan 2024
18:13 CET
NORDIC AQUA PARTNERS AS Nordic Aqua Partners AS: Tom Johan Austrheim appointed as new CFO in Nordic Aqua Partners AS 45102010 Farming, Fishing, Ranching and Plantations Additional regulated information required to be disclosed under the laws of a Member State
31 Jan 2024
18:10 CET
VOLTALIA Voltalia SA : Croissance du chiffre d’affaires de +20% au T4 2023 65101010 Alternative Electricity Other subject
31 Jan 2024
18:10 CET
VOLTALIA Voltalia SA: Turnover growth of +20% in Q4 2023 65101010 Alternative Electricity Other subject
31 Jan 2024
18:05 CET
ALGREEN ALGREEN : Résultats semestriel 2023/2024 45201010 Food Retailers and Wholesalers Legal
31 Jan 2024
18:01 CET
EMOVA GROUP Emova Group - Résultats annuels 2022/23 et Volume d\'affaires T1 2023/24 40401030 Specialty Retailers Income
31 Jan 2024
18:00 CET
AUDACIA Audacia SAS: Obligations Relance : Audacia déploie avec succès 80 M€ auprès de 20 entreprises françaises pour soutenir leur développement et leur transformation 30202010 Asset Managers and Custodians Other subject
31 Jan 2024
18:00 CET
TME PHARMA TME Pharma N.V.: Half-yearly Report on the Liquidity Contract With Invest Securities 20103010 Biotechnology Share history
31 Jan 2024
18:00 CET
XILAM ANIMATION Xilam Animation, engagé dans la transition environnementale, dévoile les résultats de son premier bilan carbone 40301035 Radio and TV Broadcasters Corporate life
31 Jan 2024
18:00 CET
BIOTALYS NV Information on the total number of voting rights and shares 55201015 Fertilizers -
31 Jan 2024
18:00 CET
TRANSITION EVERGREEN Activité des participations de Transition Evergreen au 4ème trimestre 2023 10102030 Computer Hardware Legal
31 Jan 2024
18:00 CET
TME PHARMA TME PHARMA N.V. : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC INVEST SECURITIES 20103010 Biotechnology Share history
31 Jan 2024
18:00 CET
OBIZ S.A. Forte dynamique en 2023 : 83,1 M EUR de chiffre d'affaires, en croissance de +108% au-delà de l'objectif annuel - Objectifs financiers 2023 confirmés et plus de +50% de croissance visée en 2024 10101020 Consumer Digital Services Legal
31 Jan 2024
18:00 CET
XILAM ANIMATION First Carbon Assessment Reflects Xilam’s Commitment to the Green Transition 40301035 Radio and TV Broadcasters Corporate life
31 Jan 2024
18:00 CET
POULAILLON ALPOU - Groupe POULAILLON - RESULTATS ANNUELS CONSOLIDES AU 30 SEPTEMBRE 2023 45102020 Food Products Income
31 Jan 2024
18:00 CET
NEOLIFE NEOLIFE annonce son résultat annuel 2023 50101035 Building Materials: Other -
31 Jan 2024
18:00 CET
COHERIS COHERIS : Chiffre d'affaires 2023 10101015 Software Sales, Income
31 Jan 2024
17:58 CET
KONGSBERG AUTOMOTIVE Kongsberg Automotive appoints Linda Nyquist-Evenrud as the new President & CEO 40101025 Auto Parts Inside information
31 Jan 2024
17:45 CET
GROUPE BERKEM  Groupe Berkem reporte la publication de son chiffre d’affaires annuel 2023 55201000 Chemicals: Diversified Sales
31 Jan 2024
17:45 CET
INFOTEL Infotel : Chiffre d’affaires 2023 de 307,5 M€. Croissance organique de +2,4%. 10101010 Computer Services Income